Monday, December 23, 2024
HomeTagsSugemalimab

Sugemalimab

CStone and Pfizer Announce NMPA Approval of Sugemalimab in Patients With Unresectable Stage Iii Non-small Cell Lung Cancer

CStone Pharmaceuticals, a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, and Pfizer Inc. announced that...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics